DNA-Encoded Library (DEL) screening

Jillion Therapeutics is a biotech company focused on CNS drug discovery, translating neuroscience into therapeutics using High-Power Screening (HPS) with DNA-Encoded Libraries (DELs) coupled with A.I. and machine learning. Its founder brings over two decades of experience from a Nobel Prize-winning lab in brain signaling and disease mechanisms. The company aims to identify novel drug candidates for neurological disorders, with potential impact on oncology and metabolic diseases.

Read more

AI and Machine LearningchemistryHigh-Power Screening (HPS)neurosciencepre-clinical drug discovery